Evidence map›Paper›PMID 32647390›Full record

ReviewIndian journal of microbiology2020

Deploying Biomolecules as Anti-COVID-19 Agents.

Sanjay K S Patel, Jung-Kul Lee, Vipin C Kalia

Open access · bronzeAbstract readReview
In one paragraph

Review in Indian journal of microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
1.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Emerging Field of Nanotechnology in Environment.Indian journal of microbiology · 2023
    Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Evaluation of TiOIndian journal of microbiology · 2022
    Review
  12. Review
  13. Nano-Therapeutics to Treat Acne Vulgaris.Indian journal of microbiology · 2022
    Review
  14. Neurological toll of COVID-19.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sanjay K S PatelDepartment of Chemical Engineering, Konkuk University, Seoul, 05029 Republic of Korea.
Jung-Kul LeeDepartment of Chemical Engineering, Konkuk University, Seoul, 05029 Republic of Korea.
Vipin C KaliaDepartment of Chemical Engineering, Konkuk University, Seoul, 05029 Republic of Korea.
Konkuk University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus (SARS-CoV-2) known as COVID-19 has emerged as a major threat to human existence. COVID-19 seems to have undergone adaptive evolution through an intermediate host, most likely bats. The flu leads to severe pneumonia that causes respiratory and multi-organ failure. The absence of any known treatment procedures, drugs, or vaccines has created panic around the World. The need is to develop rapid testing kits, drugs and vaccines. However, these proposals are time-consuming processes. At present social distancing along with previously known traditional medicines can act as quick and short-term alternatives for treating this viral flu.

Indexed as

BatCorona virusDiseaseHumanTransmission

Identifiers

PMID32647390
PMCPMC7282542
OpenAlexW3033838290

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.